Viral Clearance Strategies for Biopharmaceutical Safety

News
Article
Pharmaceutical TechnologyPharmaceutical Technology-06-02-2001
Volume 25
Issue 6

Special considerations and cautions must be adhered to when designing virus safety studies and developing appropriate virus contamination control programs.

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development